Related Experiment Video
Updated: Feb 9, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
[Resolved Problems of EGFR Mutation Detection Reagent Registration Application]
Chuansong Wu1, Jie Huang2, Juanjuan An1
1Center for Medical Devices Evaluation of CFDA, Beijing, 100044.
Abstract:
Cancer treatment-related gene mutation detection reagent develops rapidly especially, human Epidermal Growth Factor Receptor (EGFR) gene mutation as a molecular target for cancer therapy has received widespread attention. In this paper, through analyzing the common problems of human EGFR gene mutation detection reagent present during the past registration application. This paper describes a solution of such problems. We hope to provide information and help for relevant personnel engaged in such products registration application.
Insights
This study addresses challenges in human Epidermal Growth Factor Receptor (EGFR) gene mutation detection reagent registration. It offers solutions to improve the approval process for these vital cancer therapy tools.
Area of Science:
- Molecular Biology
- Oncology
- Biotechnology
Background:
- Cancer treatment increasingly relies on molecularly targeted therapies.
- Detection reagents for specific gene mutations, like human Epidermal Growth Factor Receptor (EGFR), are crucial for personalized medicine.
- Rapid development in this field presents regulatory challenges.
Purpose of the Study:
- To analyze common problems encountered during the registration of human EGFR gene mutation detection reagents.
- To propose solutions for overcoming these regulatory hurdles.
- To provide guidance for personnel involved in product registration.
Main Methods:
- Review of past registration application data for EGFR mutation detection reagents.
- Analysis of recurring issues and challenges.
- Development of a proposed solution framework.
Main Results:
- Identification of key obstacles in the registration process.
- A structured approach to address identified problems.
- Recommendations for streamlining regulatory submissions.
Conclusions:
- Addressing common registration issues can accelerate the availability of essential cancer diagnostic tools.
- Standardized solutions can improve the efficiency of regulatory review for gene mutation detection reagents.
- This work aims to facilitate the successful registration of EGFR mutation detection products.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
EDTA: Auxiliary Complexing Reagents
Mutation, Gene Flow, and Genetic Drift
Point and Frameshift Mutations

